177 related articles for article (PubMed ID: 33626191)
1. Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Nie C; Zhu C; Xiao M; Yang Q; Meng Y; Wu R; Wang S
Clin Cardiol; 2021 Apr; 44(4):555-562. PubMed ID: 33626191
[TBL] [Abstract][Full Text] [Related]
2. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Wang S; Cui H; Song C; Zhu C; Wu R; Meng L; Yu Q; Huang X; Wang S
Heart Rhythm; 2019 May; 16(5):694-701. PubMed ID: 30576881
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
4. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S
Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598
[TBL] [Abstract][Full Text] [Related]
5. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
[TBL] [Abstract][Full Text] [Related]
6. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
Hen Y; Iguchi N; Machida H; Takada K; Utanohara Y; Sumiyoshi T
Heart Vessels; 2013 Nov; 28(6):742-9. PubMed ID: 23097076
[TBL] [Abstract][Full Text] [Related]
7. Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters.
Di Salvo G; Pacileo G; Limongelli G; Baldini L; Rea A; Verrengia M; D'Andrea A; Russo MG; Calabrò R
J Am Soc Echocardiogr; 2010 Jun; 23(6):581-90. PubMed ID: 20362415
[TBL] [Abstract][Full Text] [Related]
8. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
[TBL] [Abstract][Full Text] [Related]
9. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
[TBL] [Abstract][Full Text] [Related]
10. The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Klopotowski M; Chojnowska L; Malek LA; Maczynska R; Kukula K; Demkow M; Witkowski A; Dabrowski M; Karcz M; Baranowski R; Kusmierczyk-Droszcz B; Kruk M; Jamiolkowski J; Kusmierczyk M; Szumowski L; Ruzyllo W
Clin Res Cardiol; 2010 May; 99(5):285-92. PubMed ID: 20148331
[TBL] [Abstract][Full Text] [Related]
11. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
[TBL] [Abstract][Full Text] [Related]
13. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
[TBL] [Abstract][Full Text] [Related]
14. Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy.
He Y; Zhou J
Am J Cardiol; 2024 Jan; 210():195-200. PubMed ID: 37884111
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
[TBL] [Abstract][Full Text] [Related]
16. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
[TBL] [Abstract][Full Text] [Related]
17. Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic-cardiomyopathy.
Chung H; Park CH; Kim Y; Kim JY; Min PK; Yoon YW; Lee KA; Lee BK; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY
Clin Cardiol; 2020 Nov; 43(11):1317-1325. PubMed ID: 32815161
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
[TBL] [Abstract][Full Text] [Related]
19. Predictors of syncope in patients with hypertrophic cardiomyopathy.
Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
[TBL] [Abstract][Full Text] [Related]
20. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
